Literature DB >> 8023820

Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic.

M Segasothy1, S A Samad, A Zulfigar, W M Bennett.   

Abstract

The risk of renal papillary necrosis and renal dysfunction due to the chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs) is unknown. In a prospective study of 259 heavy analgesic users seen in a general medical hospital over an 11-year-period beginning in January 1982, 69 new cases of analgesic nephropathy with renal papillary necrosis were confirmed by intravenous urogram (26.6%), ultrasonography (30.4%), and/or computed tomography (43%). Twenty-nine of these patients (42%) had consumed excessive quantities of NSAIDs alone; an additional nine patients (13%) had consumed NSAIDs predominantly in combinations with paracetamol, aspirin, phenacetin, caffeine, and/or traditional herbal medications. Of those patients who consumed NSAIDs alone, 17 had consumed only a single type of NSAID and the remaining 12 had consumed multiple types of NSAIDs. The amount of NSAIDs administered ranged from 1,000 to 26,600 capsules or tablets over a 2- to 25-year period. Renal impairment (serum creatinine, 126 to 778 mumol/L) was noted in 26 of these 38 patients (64.8%). The reasons given for consuming NSAIDs include gouty arthritis (18 patients), osteoarthritis (seven patients), rheumatoid arthritis (six patients), chronic headache (three patients), gouty arthritis plus chronic headache (three patients), and chronic backache (one patient). All patients were prescribed these drugs and were followed medically. The occurrence of analgesic nephropathy was predominantly in males (male to female ratio, 1.9:1). Most of the patients did not have the characteristic psychological profile attributed previously to analgesic abuse nephropathy. Associated addictive habits, such as the use of psychotropic drugs and sleeping tablets, purgative abuse, and alcoholism, were absent.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8023820     DOI: 10.1016/s0272-6386(12)80155-7

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  13 in total

Review 1.  Analgesic abuse in the elderly. Renal sequelae and management.

Authors:  M M Elseviers; M E De Broe
Journal:  Drugs Aging       Date:  1998-05       Impact factor: 3.923

2.  Prospective evaluation of analgesic use and risk of renal cell cancer.

Authors:  Eunyoung Cho; Gary Curhan; Susan E Hankinson; Philip Kantoff; Michael B Atkins; Meir Stampfer; Toni K Choueiri
Journal:  Arch Intern Med       Date:  2011-09-12

3.  Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.

Authors:  J L Wallace; W McKnight; P Del Soldato; A R Baydoun; G Cirino
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

4.  Renal Medullary Interstitial COX-2 (Cyclooxygenase-2) Is Essential in Preventing Salt-Sensitive Hypertension and Maintaining Renal Inner Medulla/Papilla Structural Integrity.

Authors:  Ming-Zhi Zhang; Suwan Wang; Yinqiu Wang; Yahua Zhang; Chuan Ming Hao; Raymond C Harris
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 5.  Renal papillary necrosis induced by naproxen.

Authors:  Larisa Kovacevic; Jay Bernstein; Rudolph P Valentini; Abubakr Imam; Neena Gupta; Tej K Mattoo
Journal:  Pediatr Nephrol       Date:  2003-05-28       Impact factor: 3.714

6.  A large cohort study of nonsteroidal anti-inflammatory drugs and renal cell carcinoma incidence in the National Institutes of Health-AARP Diet and Health Study.

Authors:  Wei Liu; Yikyung Park; Mark P Purdue; Edward Giovannucci; Eunyoung Cho
Journal:  Cancer Causes Control       Date:  2013-07-19       Impact factor: 2.506

7.  Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studies.

Authors:  Toni K Choueiri; Youjin Je; Eunyoung Cho
Journal:  Int J Cancer       Date:  2013-09-23       Impact factor: 7.396

Review 8.  Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity.

Authors:  G R Matzke; R F Frye
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

9.  In vivo regulation of MAP kinases in Ratus norvegicus renal papilla by water loading and restriction.

Authors:  P A Wojtaszek; L E Heasley; T Berl
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

10.  Modulation of carcinogen metabolism by nitric oxide-aspirin 2 is associated with suppression of DNA damage and DNA adduct formation.

Authors:  Christopher J MacDonald; Robert Y S Cheng; David D Roberts; David A Wink; Grace Chao Yeh
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.